FDA
-
-
-
-
-
-
-
Zosano Pharma (ZSAN) SVP Operations Hayley Lewis to Resign; Refines Resubmission of M207 NDA
-
-
-
-
-
-
-
Zosano Pharma (ZSAN) Appoints Industry Veteran, Kathy McGee, to its Board of Directors
-
-
-
-
-
-
-
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2020 Financial Results
-
-
-
-
-
-
-
Zosano Pharma Requests Type A Meeting with the FDA to Review Resubmission Plans for Qtrypta™ New Drug Application
-
-
-
-
-
-
-
Zosano Pharma Reports Third Quarter 2020 Financial Results
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/01: (AEL) (AMAG) (BBBY) Higher; (ZSAN) (LOGC) (SPI) Lower (more...)
-
-
-
-
-
-
-
Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

